دورية أكاديمية

Biological Clock Genes are Crucial and Promising Biomarkers for the Therapeutic Targets and Prognostic Assessment in Gastric Cancer.

التفاصيل البيبلوغرافية
العنوان: Biological Clock Genes are Crucial and Promising Biomarkers for the Therapeutic Targets and Prognostic Assessment in Gastric Cancer.
المؤلفون: Tian Y; Department of Gastroenterology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, 730030, Gansu Province, China., Xie Y; The Gastroenterology Clinical Medical Center of Hainan Province, Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou City, China., Bai F; The Gastroenterology Clinical Medical Center of Hainan Province, Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou City, China. baifeihu@sohu.com., Wang J; Department of Gastroenterology, 986 Hospital, Xijing Hospital, Air Force Military Medical University, No. 269, Youyi East Road, Xi'an, Shaanxi Province, 710089, China. wangjundoctor@aliyun.com., Zhang D; Department of Gastroenterology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, 730030, Gansu Province, China. zhangdk8616@126.com.
المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Jun; Vol. 55 (2), pp. 900-912. Date of Electronic Publication: 2024 Mar 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Science+Business Media Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: 2010- : New York : Springer Science+Business Media
Original Publication: New York, NY : Humana Press
مواضيع طبية MeSH: Stomach Neoplasms*/genetics , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/metabolism , CLOCK Proteins*/genetics, Humans ; Prognosis ; Circadian Clocks/genetics ; Period Circadian Proteins/genetics ; Gene Expression Regulation, Neoplastic ; Computational Biology ; Circadian Rhythm/genetics ; Cell Cycle Proteins ; Intracellular Signaling Peptides and Proteins ; Nuclear Receptor Subfamily 1, Group D, Member 1
مستخلص: Background: Gastric cancer is one of the major public health problems worldwide. Circadian rhythm disturbances driven by circadian clock genes play a role in the development of cancer. However, whether circadian clock genes can serve as potential therapeutic targets and prognostic biomarkers for gastric cancer remains elusive.
Methods: In this study, we comprehensively analyzed the potential relationship between circadian clock genes and gastric cancer using online bioinformatics databases such as GEPIA, cBioPortal, STRING, GeneMANIA, Metascape, TIMER, TRRUST, and GEDS.
Results: Biological clock genes are expressed differently in human tumors. Compared with normal tissues, only PER1, CLOCK, and TIMELESS expression differences were statistically significant in gastric cancer (p < 0.05). PER1 (p = 0.0169) and CLOCK (p = 0.0414) were associated with gastric cancer pathological stage (p < 0.05). Gastric cancer patients with high expression of PER1 (p = 0.0028) and NR1D1 (p = 0.016) had longer overall survival, while those with high expression of PER1 (p = 0.042) and NR1D1 (p = 0.016) had longer disease-free survival. The main function of the biological clock gene is related to the circadian rhythms and melatonin metabolism and effects. CLOCK, NPAS2, and KAT2B were key transcription factors for circadian clock genes. In addition, we also found important correlations between circadian clock genes and various immune cells in the gastric cancer microenvironment.
Conclusions: This study may establish a new gastric cancer prognostic indicator based on the biological clock gene and develop new drugs for the treatment of gastric cancer using biological clock gene targets.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (London, England). 2020;396:635–48. (PMID: 10.1016/S0140-6736(20)31288-5)
Chidambaram S, Sounderajah V, Maynard N, Markar SR. ASO author reflections: applications of artificial intelligence in oesophago-gastric malignancies-present work and future directions. Ann Surg Oncol. 2022;29:1991–2. (PMID: 10.1245/s10434-021-10907-0)
Oura H, Matsumura T, Fujie M, Ishikawa T, Nagashima A, Shiratori W, Tokunaga M, Kaneko T, Imai Y, Oike T, Yokoyama Y, Akizue N, Ota Y, Okimoto K, Arai M, Nakagawa Y, Inada M, Yamaguchi K, Kato J, Kato N. Development and evaluation of a double-check support system using artificial intelligence in endoscopic screening for gastric cancer. Gastric Cancer. 2022;25:392–400. (PMID: 10.1007/s10120-021-01256-8)
Rugge M. Big data on gastric dysplasia support gastric cancer prevention. Clin Gastroenterol Hepatol. 2022;20:1226–8. (PMID: 10.1016/j.cgh.2022.01.038)
Guo C, Liu Z, Yu Y, Liu S, Ma K, Ge X, Xing Z, Lu T, Weng S, Wang L, Liu L, Hua Z, Han X, Li Z. Integrated analysis of multi-omics alteration, immune profile, and pharmacological landscape of pyroptosis-derived lncRNA Pairs in gastric cancer. Front Cell Dev Biol. 2022;10:816153. (PMID: 10.3389/fcell.2022.816153)
Wang Z, Su G, Dai Z, Meng M, Zhang H, Fan F, Liu Z, Zhang L, Weygant N, He F, Fang N, Zhang L, Cheng Q. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation. Cell Prolif. 2021;54:e12988. (PMID: 10.1111/cpr.12988)
Mastrullo V, van der Veen DR, Gupta P, Matos RS, Johnston JD, McVey JH, Madeddu P, Velliou EG, Campagnolo P. Pericytes’ circadian clock affects endothelial cells’ synchronization and angiogenesis in a 3D tissue engineered scaffold. Front Pharmacol. 2022;13:867070. (PMID: 10.3389/fphar.2022.867070)
Guan D, Lazar MA. Interconnections between circadian clocks and metabolism. J Clin Investig. 2021;131:e148278. (PMID: 10.1172/JCI148278)
Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, Roh JH, Ortiz-Gonzalez X, Dearborn JT, Culver JP, Herzog ED, Hogenesch JB, Wozniak DF, Dikranian K, Giasson BI, Weaver DR, Holtzman DM, Fitzgerald GA. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Investig. 2013;123:5389–400. (PMID: 10.1172/JCI70317)
Xu H, Huang L, Zhao J, Chen S, Liu J, Li G. The circadian clock and inflammation: a new insight. Clin Chim Acta. 2021;512:12–7. (PMID: 10.1016/j.cca.2020.11.011)
Fagiani F, Di Marino D, Romagnoli A, Travelli C, Voltan D, Mannelli LDC, Racchi M, Govoni S, Lanni C. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther. 2022;7:41. (PMID: 10.1038/s41392-022-00899-y)
Allada R, Bass J. Circadian mechanisms in medicine. N Engl J Med. 2021;384:550–61. (PMID: 10.1056/NEJMra1802337)
Jiang Y, Shen X, Fasae MB, Zhi F, Chai L, Ou Y, Feng H, Liu S, Liu Y, Yang S. The expression and function of circadian rhythm genes in hepatocellular carcinoma. Oxid Med Cell Longev. 2021;2021:4044606. (PMID: 10.1155/2021/4044606)
Rajendran S, Benna C, Marchet A, Nitti D, Mocellin S. Germline polymorphisms of circadian genes and gastric cancer predisposition. Cancer Commun (London, England). 2020;40:234–8. (PMID: 10.1002/cac2.12008)
Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH, Liu YC, Lin HY, Lin SF, Yang MY. Deregulated expression of circadian clock genes in gastric cancer. BMC Gastroenterol. 2014;14:67. (PMID: 10.1186/1471-230X-14-67)
Huang Z, He A, Wang J, Lu H, Zhang R, Wu L, Feng Q. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma. Aging. 2021;13:16637–55. (PMID: 10.18632/aging.203184)
Rajendran S, Benna C, Monticelli H, Spiro G, Menin C, Mocellin S. Germline variation of circadian pathway genes and prognosis of gastric cancer patients. Gut. 2018;67:779–80.
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–w102. (PMID: 10.1093/nar/gkx247)
Unberath P, Knell C, Prokosch HU, Christoph J. Developing new analysis functions for a translational research platform: extending the cBioPortal for cancer genomics. Stud Health Technol Inform. 2019;258:46–50.
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C, The STRING. customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(2021):D605–d612. (PMID: 10.1093/nar/gkaa1074)
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C, The STRING database. 2017 quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362–d368. (PMID: 10.1093/nar/gkw937)
Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60–w64. (PMID: 10.1093/nar/gky311)
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. (PMID: 10.1038/s41467-019-09234-6)
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Can Res. 2017;77:e108–10. (PMID: 10.1158/0008-5472.CAN-17-0307)
Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, Yang S, Kim CY, Lee M, Kim E, Lee S, Kang B, Jeong D, Kim Y, Jeon HN, Jung H, Nam S, Chung M, Kim JH, Lee I. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46:D380–d386. (PMID: 10.1093/nar/gkx1013)
Ren F, Zhao Q, Zhao M, Zhu S, Liu B, Bukhari I, Zhang K, Wu W, Fu Y, Yu Y, Tang Y, Zheng P, Mi Y. Immune infiltration profiling in gastric cancer and their clinical implications. Cancer Sci. 2021;112:3569–84. (PMID: 10.1111/cas.15057)
Wu M, Wang Y, Liu H, Song J, Ding J. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer. Biosci Rep. 2020;40:BSR20193308. (PMID: 10.1042/BSR20193308)
Yang Y, He W, Wang ZR, Wang YJ, Li LL, Lu JZ, Tao Y, Zhang J, Fu SJ, Wang ZP, Liu SH. Immune cell landscape in gastric cancer. Biomed Res Int. 2021;2021:1930706.
Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, Amani M, Fitzmaurice C, Nixon M, Abbasi N, Abolhassani H. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42–54. (PMID: 10.1016/S2468-1253(19)30328-0)
Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534–42. (PMID: 10.1016/j.cgh.2019.07.045)
Ruan W, Yuan X, Eltzschig HK. Circadian rhythm as a therapeutic target. Nat Rev Drug Discov. 2021;20:287–307. (PMID: 10.1038/s41573-020-00109-w)
Sulli G, Lam MTY, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends Cancer. 2019;5:475–94. (PMID: 10.1016/j.trecan.2019.07.002)
Malik S, Stokes Iii J, Manne U, Singh R, Mishra MK. Understanding the significance of biological clock and its impact on cancer incidence. Cancer Lett. 2022;527:80–94. (PMID: 10.1016/j.canlet.2021.12.006)
Xu L, Lin J, Liu Y, Hua B, Cheng Q, Lin C, Yan Z, Wang Y, Sun N, Qian R, Lu C. CLOCK regulates Drp1 mRNA stability and mitochondrial homeostasis by interacting with PUF60. Cell Rep. 2022;39:110635. (PMID: 10.1016/j.celrep.2022.110635)
Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu XY, Han J, Liu KY, Liao JW, Xu RH, Zou QF. Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. Int J Clin Exp Pathol. 2014;7:619–30.
Hernández-Rosas F, Hernández-Oliveras A, Flores-Peredo L, Rodríguez G, Zarain-Herzberg Á, Caba M, Santiago-García J. Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells. Oncol Lett. 2018;16:1981–90.
Wang X, Jia R, Chen K, Wang J, Jiang K, Wang Z. RORα and REV-ERBα are associated with clinicopathological parameters and are independent biomarkers of prognosis in gastric cancer. Technol Cancer Res Treat. 2021;20:15330338211039670. (PMID: 10.1177/15330338211039670)
Zhang R, Li H, Li N, Shi JF, Li J, Chen HD, Yu YW, Qin C, Ren JS, Chen WQ, He J. Risk factors for gastric cancer: A large-scale, population-based case-control study. Chin Med J. 2021;134:1952–8. (PMID: 10.1097/CM9.0000000000001652)
Soták M, Sumová A, Pácha J. Cross-talk between the circadian clock and the cell cycle in cancer. Ann Med. 2014;46:221–32. (PMID: 10.3109/07853890.2014.892296)
Koritala BSC, Porter KI, Arshad OA, Gajula RP, Mitchell HD, Arman T, Manjanatha MG, Teeguarden J, Van Dongen HPA, McDermott JE, Gaddameedhi S. Night shift schedule causes circadian dysregulation of DNA repair genes and elevated DNA damage in humans. J Pineal Res. 2021;70:e12726. (PMID: 10.1111/jpi.12726)
Shafi AA, Knudsen KE. Cancer and the circadian clock. Can Res. 2019;79:3806–14. (PMID: 10.1158/0008-5472.CAN-19-0566)
Sokolova O, Naumann M. NF-κb signaling in gastric cancer. Toxins. 2017;9:119. (PMID: 10.3390/toxins9040119)
Zhang Z, Zeng P, Gao W, Zhou Q, Feng T, Tian X. Circadian clock: a regulator of the immunity in cancer. Cell Commun Signal. 2021;19:37. (PMID: 10.1186/s12964-021-00721-2)
Cash E, Sephton S, Woolley C, Elbehi AM, Ri A, Ekine-Afolabi B, Kok VC. The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics. J Exp Clin Cancer Res. 2021;40:119. (PMID: 10.1186/s13046-021-01919-5)
He X, Cao Y, Gu Y, Fang H, Wang J, Liu X, Lv K, Yu K, Fei Y, Lin C, Liu H, Zhang H, Li H, Xu J, Li R, He H. Clinical outcomes and immune metrics in intratumoral basophil-enriched gastric cancer patients. Ann Surg Oncol. 2021;28:6439–50. (PMID: 10.1245/s10434-021-09815-0)
Jin Y, Tao L, Jin S, Cai W. Patterns of immune infiltration in gastric cancer and their clinical significance. Jpn J Clin Oncol. 2021;51:1067–79. (PMID: 10.1093/jjco/hyab054)
Mao C, Ma L, Huang Y, Yang X, Huang H, Cai W, Sitrakiniaina A, Gu R, Xue X, Shen X. Immunogenomic landscape and immune-related gene-based prognostic signature in asian gastric cancer. Front Oncol. 2021;11:750768. (PMID: 10.3389/fonc.2021.750768)
Wang Y, Sun J, Yang Y, Zebaze Dongmo S, Qian Y, Wang Z. Identification and development of subtypes with poor prognosis in gastric cancer based on both hypoxia and immune cell infiltration. Int J Gen Med. 2021;14:9379–99. (PMID: 10.2147/IJGM.S326647)
معلومات مُعتمدة: 2021818 Hainan Province Clinical Medical Center; 2022136 the specific research fund of The Innovation Platform for Academicians of Hainan Province; 22A200078 Hainan Provincial Health Industry Research Project; lzuyxcx-2022-181 Medical Innovation and Development Project of Lanzhou University
فهرسة مساهمة: Keywords: Bioinformatics; Biological clock genes; Gastric adenocarcinoma; Genetic alterations; Signaling pathways; Tumor microenvironment
المشرفين على المادة: 0 (Biomarkers, Tumor)
EC 2.3.1.48 (CLOCK Proteins)
0 (PER1 protein, human)
EC 2.3.1.48 (CLOCK protein, human)
0 (Period Circadian Proteins)
0 (NR1D1 protein, human)
0 (TIMELESS protein, human)
0 (Cell Cycle Proteins)
0 (Intracellular Signaling Peptides and Proteins)
0 (Nuclear Receptor Subfamily 1, Group D, Member 1)
تواريخ الأحداث: Date Created: 20240301 Date Completed: 20240619 Latest Revision: 20240619
رمز التحديث: 20240619
DOI: 10.1007/s12029-024-01028-4
PMID: 38427147
قاعدة البيانات: MEDLINE
الوصف
تدمد:1941-6636
DOI:10.1007/s12029-024-01028-4